Exoderil cream, 15 g, Sandoz

Exoderil cream, 15 g, Sandoz

Regular price
Sale price
Regular price
Sold out
Unit price
Tax included. Shipping calculated at checkout.

Exoderil cream, 15 g, Sandoz 

Exoderil is indicated in: fungal infections of the skin or skin folds (Tinea corporis, Tinea înguinalis); interdigital mycoses (Tinea manum, Tinea pedum); fungal nail infections; skin infections with candida; pityriasis versicolor; inflammatory dermatomycoses (with or without pruritus).

Exoderil is an antifungal agent for external applications. The active substance of the product is naftifine. Naftifina is active against dermatophyte skin fungi, e.g. trichophyton, micro spoon and epidermophyte species), yeasts (Candida species, Pityriasis versicolor), fungi (Aspergillus species) and other fungi (eg Sporothrix schenkii). In the case of dermatophytes and Aspergillus species, naftifine is a fungicide. in vitro. In the case of yeasts, naftifine is either fungicidal or fungistatic depending on the type of strain involved. In addition to its antifungal action, naftifine also has antibacterial activity acting on a wide range of gram-positive or gram-negative microorganisms that frequently occur in association with fungal disease. From a clinical point of view, naftifine has also been shown to have an intrinsic anti-inflammatory action, which leads to a rapid reduction of inflammatory symptoms, especially pruritus. Because it penetrates rapidly into the skin and is present in persistent antifungal concentrations in different layers of the skin, Exoderil can be administered only once a day in local applications.

1 g of cream contains: naphthaphine hydrochloride 10 mg and benzyl alcohol as a preservative 10 mg.

Method of administration:
To be administered in local applications only at the level of the skin or nails. Exoderil is applied topically once a day to the affected area and the surrounding area after it has been cleaned and dried beforehand. To prevent recurrences, it is recommended that Exoderil be administered for at least another 2 weeks after clinical cure.

Pregnancy and breast-feeding: There is no known effect of Exoderil on the fetus or the baby if this product is used properly. Teratogenesis studies did not reveal any embryotoxic effects of naftifine.

Side effects:
Sporadically, there may be signs of local irritation such as dryness, heat and erythema. Side effects are always reversible and do not require discontinuation of treatment. Special warnings: Avoid contact with eyes with Exoderil cream.

Hypersensitivity to naftifine or to benzyl alcohol (preservative).

15 g